Genefluidics

Irwindale, United States Founded: 2000 • Age: 26 yrs
Electrochemical sensor for rapid diagnosis of urinary tract infections (UTIs)

About Genefluidics

Genefluidics is a company based in Irwindale (United States) founded in 2000.. Genefluidics operates in a competitive market with competitors including Bright Uro, DNC Biotechnology, Clinical Design, Stream DX and COBIO Smart Healthcare Technology, among others.

  • Headquarter Irwindale, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $4.61 M (USD), Grant

    May 01, 2015

  • Investors
    UCLA

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Genefluidics

  • Total Funding
  • Total Rounds 9
  • Last Round Grant — $4.6M
  • First Round

    (20 Mar 2004)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2015 Amount Grant - Genefluidics Valuation

investors

HHS
Mar, 2015 Amount Grant - Genefluidics Valuation

investors

HHS
May, 2012 Amount Grant - Genefluidics Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Genefluidics

Genefluidics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UCLA and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Undergraduate and postgraduate courses are offered across diversified streams.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Genefluidics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Genefluidics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genefluidics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Genefluidics

Genefluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bright Uro, DNC Biotechnology, Clinical Design, Stream DX and COBIO Smart Healthcare Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diagnostic devices for lower urinary tract diseases are developed.
domain founded_year HQ Location
In vitro diagnostic devices for urine infection detection are developed.
domain founded_year HQ Location
A patented urine diagnostic device for ten parameters is developed.
domain founded_year HQ Location
Uro-flow meters for LUTS diagnosis and patient care are provided.
domain founded_year HQ Location
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
domain founded_year HQ Location
Provides DIY test kits for benign prostatic hyperplasia (BPH).
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genefluidics

Frequently Asked Questions about Genefluidics

When was Genefluidics founded?

Genefluidics was founded in 2000 and raised its 1st funding round 4 years after it was founded.

Where is Genefluidics located?

Genefluidics is headquartered in Irwindale, United States. It is registered at Irwindale, California, United States.

What does Genefluidics do?

GeneFluidics is a biomedical diagnostics company engaged in the development of rapid tests for detection of direct bloodstream infection (BSI), pathogen identification (PID) and antimicrobial susceptibility tests (AST). The company has integrated the concepts of bio-nano, microfluidic technologies and its proprietary electrochemical sensor to develop a molecular analysis platform that allows users to perform rapid immunoassays and genetic assays with sensitivity to picogramml and femtomolar concentrations, respectively. The company has developed a modular robotic system-Proteus, the multi-channel microfluidics cartridge system-Asklepios, and sensor chip arrays. The Proteus Robotic System allows quantification of multiple proteins, nucleic acids and small molecules simultaneously. The company plans to complete the clinical testing for CE marking for Proteus lab automation system, allows rapid PID and AST of urinary tract infections (UTIs) by 2016.

Who are the top competitors of Genefluidics?

Genefluidics's top competitors include Bright Uro, DNC Biotechnology and Clinical Design.

Who are Genefluidics's investors?

Genefluidics has 2 investors. Key investors include UCLA, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available